Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.70 -0.76 (-5.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Revenue (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) reported Revenue of $2.96 million for Q2 2026, down 89.5% from $28.3 million a year earlier but up 43.6% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Revenue (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Arcturus Therapeutics Holdings' Revenue came in at $29.37 million, down 76.0% year-over-year; for FY2025, it was $82.03 million, down 46.1% from FY2024.

  • Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 53.8% (FY2020 to FY2025).
  • By year, Revenue came in at $152.31 million in FY2024 (-8.7%), $166.8 million in FY2023 (-19.0%), $206 million in FY2022 and $12.36 million in FY2021 (+29.6%).
  • Five-year quarterly Revenue spans a low of $2.06 million in Q1 2026 and a high of $160.29 million in Q4 2022.
  • Year over year, Revenue has now declined in each of the last eight quarters, with an average decline of 51.2% over the last eight quarters.
  • The high point for year-over-year Revenue in five years was Q3 2022 (growth of 448.6%); the low point was Q1 2026 (a decline of 93.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.06 million (Q1 2026), $7.2 million (Q4 2025) and $17.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Arcturus Therapeutics Holdings 411.00 Mn -403.13 Mn - 2.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.96 Mn
Mar 31, 2026 2.06 Mn
Dec 31, 2025 7.20 Mn
Sep 30, 2025 17.15 Mn
Jun 30, 2025 28.30 Mn
Mar 31, 2025 29.38 Mn
Dec 31, 2024 22.77 Mn
Sep 30, 2024 41.67 Mn
Jun 30, 2024 49.86 Mn
Mar 31, 2024 38.01 Mn
Dec 31, 2023 30.86 Mn
Sep 30, 2023 45.14 Mn
Jun 30, 2023 10.52 Mn
Mar 31, 2023 80.29 Mn
Dec 31, 2022 160.29 Mn
Sep 30, 2022 13.37 Mn
Jun 30, 2022 27.09 Mn
Mar 31, 2022 5.24 Mn
Dec 31, 2021 5.79 Mn
Sep 30, 2021 2.44 Mn
API Access

Arcturus Therapeutics Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ARCT&period=max&api_key=YOUR_API_KEY